BDNF is known to facilitate neurogenesis, neuroprotection, and neuroregeneration (6), and reduced BDNF concentration is observed in patients with CAD (7), and may constitute a pathogenic factor common to Alzheimer’s disease (8). This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.